Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanthi Marur

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2013
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 yearsVasavi Paidpally, Abdel K Tahari, Stella Lam, et al.
Head & Neck|January 24, 2012
Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapyGiuseppe Sanguineti, Francesco Ricchetti, Binbin Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancerGiuseppe Sanguineti, Maria Pia Sormani, Shanthi Marur, et al.
The Journal of Urology|May 19, 2009
Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancerUlka N Vaishampayan, Shanthi Marur, Lance K Heilbrun, et al.
Surgery|November 20, 2012
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancerJulie A Sosa, Jai Balkissoon, Shiao-ping Lu, et al.
Cancer Medicine|August 10, 2013
Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancerAnne Tsao, Edwin Pun Hui, Rosalyn Juergens, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 21, 2012
Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinomaJason Y K Chan, Giuseppe Sanguineti, Jeremy D Richmon, et al.
Oral Oncology|December 26, 2015
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinomaChristine H Chung, Michelle A Rudek, Hyunseok Kang, et al.
Oral Oncology|June 19, 2018
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinomaRenata Ferrarotto, William N William, Jennifer E Tseng, et al.
Thyroid : Official Journal of the American Thyroid Association|June 1, 2013
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinomaJulie A Sosa, Rossella Elisei, Barbara Jarzab, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2013
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 yearsVasavi Paidpally, Abdel K Tahari, Stella Lam, et al.
Head & Neck|January 24, 2012
Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapyGiuseppe Sanguineti, Francesco Ricchetti, Binbin Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancerGiuseppe Sanguineti, Maria Pia Sormani, Shanthi Marur, et al.
The Journal of Urology|May 19, 2009
Phase II trial of capecitabine and weekly docetaxel for metastatic castrate resistant prostate cancerUlka N Vaishampayan, Shanthi Marur, Lance K Heilbrun, et al.
Surgery|November 20, 2012
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancerJulie A Sosa, Jai Balkissoon, Shiao-ping Lu, et al.
Cancer Medicine|August 10, 2013
Phase II study of TAS-106 in patients with platinum-failure recurrent or metastatic head and neck cancer and nasopharyngeal cancerAnne Tsao, Edwin Pun Hui, Rosalyn Juergens, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 21, 2012
Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinomaJason Y K Chan, Giuseppe Sanguineti, Jeremy D Richmon, et al.
Oral Oncology|December 26, 2015
A phase I study afatinib/carboplatin/paclitaxel induction chemotherapy followed by standard chemoradiation in HPV-negative or high-risk HPV-positive locally advanced stage III/IVa/IVb head and neck squamous cell carcinomaChristine H Chung, Michelle A Rudek, Hyunseok Kang, et al.
Oral Oncology|June 19, 2018
Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinomaRenata Ferrarotto, William N William, Jennifer E Tseng, et al.
Thyroid : Official Journal of the American Thyroid Association|June 1, 2013
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinomaJulie A Sosa, Rossella Elisei, Barbara Jarzab, et al.
Pageof 4